- Anti-obesity medication Zepbound (tirzepatide) delivers significant weight loss even in people with multiple obesity-related medical conditions, a new study found.
- The research challenges the concept that people with chronic health issues linked to obesity lose less weight than healthier individuals.
- The findings suggest that tirzepatide is effective regardless of the number of obesity-associated diseases a person may have.
Obesity is known to cause or exacerbate
Read the full article here